Measuring microplastic exposure in patients using clear aligners

Microplastic Exposure From Clear Aligner Wear: An In Vivo, Longitudinal Study of Orthodontic Patients

University of North Carolina, Chapel Hill · NCT06934603

This study is trying to see how clear aligners might affect the levels of microplastics in the saliva and urine of orthodontic patients over time.

Quick facts

Study typeObservational
Enrollment150 (estimated)
Ages10 Years to 75 Years
SexAll
SponsorUniversity of North Carolina, Chapel Hill (other)
Locations1 site (Chapel Hill, North Carolina)
Trial IDNCT06934603 on ClinicalTrials.gov

What this trial studies

This observational study investigates the levels of microplastic exposure and physiological uptake in orthodontic patients undergoing clear aligner treatment. Participants will provide saliva and urine samples at three different time points: before treatment, 6-12 weeks after starting treatment, and 16-24 weeks after treatment begins. The samples will be analyzed for microplastic content using advanced techniques such as mass spectroscopy, Raman spectroscopy, and scanning electron microscopy. The goal is to understand how clear aligners may influence microplastic exposure over time.

Who should consider this trial

Good fit: Ideal candidates are individuals aged 10 to 90 years who are scheduled for comprehensive orthodontic treatment with clear aligners and are in stable health.

Not a fit: Patients receiving fixed orthodontic appliances or those with severe oral health issues may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could provide insights into the health implications of microplastic exposure from dental treatments.

How similar studies have performed: While the investigation of microplastic exposure is a growing field, this specific approach in orthodontic patients is novel and has not been extensively tested in prior studies.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Individuals (all sexes, genders, races, and ethnicities) aged at least 10 years (in adult dentition) and at most 75 years
* Receiving comprehensive, Phase II orthodontic treatment with clear aligner therapy
* Stable physical health (ASA I or II), as determined by study coordinator or PI
* Able to comprehend and follow requirements of study (including availability on scheduled visit dates)
* Patient and parental consent (and assent for minors) for participation in the study

Exclusion Criteria:

* Receiving orthodontic treatment with fixed appliances
* Receiving hybrid treatment with fixed appliances and aligners
* Receiving Phase I orthodontic treatment with fixed appliances
* Established history of severe xerostomia (dry mouth), severe periodontal disease with actively bleeding gums, significant oral abrasions/ulcers or growths, current alcohol abuse, and/or recreational drug abuse
* Other severe acute or chronic medical or psychiatric condition or laboratory abnormality that may increase risk associated with participation
* Drinking, eating, or brushing teeth within 1 hour of study visit
* Removing aligners within 1 hour of study visit
* Developmental or cognitive disability such that the patient cannot self-consent, comprehend, and follow the requirements of the study based on research site personnel's assessment

Where this trial is running

Chapel Hill, North Carolina

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Microplastic Exposure

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.